Rheumatic Fever News and Research

RSS
Rheumatic fever is an inflammatory disease that may develop two to three weeks after a Group A streptococcal infection (such as strep throat or scarlet fever). It is believed to be caused by antibody cross-reactivity and can involve the heart, joints, skin, and brain.
Health officials discuss new strategies to prevent rheumatic fever, rheumatic heart disease

Health officials discuss new strategies to prevent rheumatic fever, rheumatic heart disease

World Heart Federation publishes position statement on rheumatic fever, rheumatic heart disease

World Heart Federation publishes position statement on rheumatic fever, rheumatic heart disease

Griffith University's Institute for Glycomics launches human trials for Streptococcus A vaccine

Griffith University's Institute for Glycomics launches human trials for Streptococcus A vaccine

FDA clears Meridian Bioscience’s new illumigene Group A Strep test

FDA clears Meridian Bioscience’s new illumigene Group A Strep test

Strep throat should be treated with penicillin or amoxicillin: IDSA guidelines

Strep throat should be treated with penicillin or amoxicillin: IDSA guidelines

Data from 2 new studies on RHD presented at World Congress of Cardiology

Data from 2 new studies on RHD presented at World Congress of Cardiology

Study finds under-treatment of RHD in India, Africa

Study finds under-treatment of RHD in India, Africa

RHD patients seek treatment in the very late stages of disease

RHD patients seek treatment in the very late stages of disease

New guidelines for detection of rheumatic heart disease

New guidelines for detection of rheumatic heart disease

University of Cape Town, UT Southwestern sign affiliation agreement

University of Cape Town, UT Southwestern sign affiliation agreement

Stony Brook University opens new center to treat valvular heart disease

Stony Brook University opens new center to treat valvular heart disease

Vaxent, PREVENT sign license agreement to develop and commercialize Strep-A vaccine

Vaxent, PREVENT sign license agreement to develop and commercialize Strep-A vaccine

Insight into how bacterial toxins cause human diseases may help improve treatment

Insight into how bacterial toxins cause human diseases may help improve treatment

U-M's CoreValve trial to offer less invasive approach for patients with aortic stenosis

U-M's CoreValve trial to offer less invasive approach for patients with aortic stenosis

U-M participates in national trial for alternative approach to open heart surgery for severe aortic stenosis

U-M participates in national trial for alternative approach to open heart surgery for severe aortic stenosis

Report finds neglected diseases research funding up in 2009, funding for related non-profits down

Report finds neglected diseases research funding up in 2009, funding for related non-profits down

Drugs against protective action of bacteria's antitoxin molecules

Drugs against protective action of bacteria's antitoxin molecules

Australian scientists uncover the secrets behind one of nature’s most extraordinary biological machines

Australian scientists uncover the secrets behind one of nature’s most extraordinary biological machines

Gene study provides new clues to fight infections

Gene study provides new clues to fight infections

Pediatric patients face number of cardiac conditions that can impact their health

Pediatric patients face number of cardiac conditions that can impact their health